articleTop 10% cited
Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial
Radiotherapy and Oncology · 2005 · Vol. 75(1) · pp. 9–17
John Yarnold✉(Royal Marsden Hospital)Anita AshtonJudith M. Bliss(Institute of Cancer Research)Janis Homewood(Institute of Cancer Research)C Harper(Institute of Cancer Research)Jane Hanson(Royal Marsden NHS Foundation Trust)Joanne Haviland(Institute of Cancer Research)Søren M. BentzenRoger Owen
Breast Cancer Treatment StudiesAdvanced Radiotherapy TechniquesCancer Risks and FactorsMedicineBreast cancerRadiation therapyAdverse effectClinical endpointMastectomyDose fractionationNuclear medicineMammary glandCancer
MeSH terms
AdenocarcinomaAdultAgedBreast NeoplasmsFemaleFollow-Up StudiesHumansMiddle AgedRadiation InjuriesRisk FactorsTime FactorsDose Fractionation, Radiation
Funding
- Cancer Research UK
Citations
509
FWCI
8.03
field-weighted impact
References
21
Percentile
98%
vs. same field & year
Citations per year
Cited by
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
The Lancet Oncology · 2013 · 1,433 citations
Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy
Radiotherapy and Oncology · 2007 · 475 citations
References
Time-dose factors in radiotherapy: a review of the human data
Radiotherapy and Oncology · 1990 · 406 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.